Integrating Dialysis in Ex Situ Machine Perfusion: A Systematic Review and Meta‐Analysis of Outcomes
Artificial Organs, EarlyView.Dialysis‐enhanced EVMP effectively maintains biochemical homeostasis, potentially mitigating metabolic stress and extending perfusion duration. Functional outcomes varied depending on the organ type, with the most pronounced benefits observed in cardiac perfusion.
Yomna E. Dean +12 more
wiley +1 more source
Adenosine triphosphate–dependent potassium channel modulation and cardioplegia-induced protection of human atrial muscle in an in vitro model of myocardial stunning [PDF]
, 2000 Francesco Monti +9 more
openalex +1 more source
Inflammatory Cytokines as Early Predictors of Weaning Failure From Extracorporeal Life Support
Artificial Organs, EarlyView.Levels of IL‐8 and IL‐6 and their dynamics are reliable early predictors of ECLS weaning failure. ABSTRACT Background Weaning from extracorporeal life support (ECLS) in patients with refractory shock still remains a complex decision. Despite considerable advances in ECLS management, reliable biomarkers to predict weaning success are still not available.
Kostiantyn Kozakov +11 more
wiley +1 more source
Myocardial Stunning With Severe Functional Mitral Regurgitation in Transcatheter Aortic Valve Replacement - Temporal Change in Transesophageal Echocardiographic Findings. [PDF]
Circ Rep, 2022 Takahashi Y +5 more
europepmc +1 more source
Takotsubo Syndrome in the Dialysis Patient - Challenging Diagnosis in a Unique Population. [PDF]
, 2019 Banerjee +9 more
core +1 more source
Artificial Organs, EarlyView.Percutaneous femoro‐femoral V‐A ECMO cannulation was associated with more than a two‐fold lower risk of site bleeding and nearly a six‐fold lower risk of infection compared with surgical cut‐down, with no difference in limb ischemia. Absence of distal perfusion catheterization and larger arterial cannula size were additional modifiable ischemia risk ...
Axel Dimberg +3 more
wiley +1 more source
Effects of lipids on the functional and metabolic recovery from global myocardial stunning in isolated rabbit hearts [PDF]
, 2000 Marc Van de Velde
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Alleviation of myocardial stunning by leukocyte and platelet depletion. [PDF]
, 1989 William Westlin, Kevin Mullane
openalex +1 more source
British Journal of Pharmacology, EarlyView.Abstract Background and Purpose Plasma glucocorticoids increase acutely after MI, thereafter tissue levels are amplified selectively within cells expressing 11‐ßhydroxysteroid dehydrogenase type 1 (11‐ßHSD1) that regenerates active glucocorticoids from circulating metabolites.
Sara Al Disi +19 more
wiley +1 more source